Live Breaking News & Updates on Pfizer Global Product Development

Stay updated with breaking news from Pfizer global product development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Approves Braftovi and Mektovi for Some Patients with Metastatic NSCLC

Braftovi (encorafenib) with Mektovi (binimetinib) has been approved for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, the agency announced on Wednesday evening. ....

Foundationone Cdx , Chris Boshoff , Pfizer Global Product Development , Drug Administration , Foundationone Liquid , Supplemental New Drug Application , Clinical Oncology , Lung Cancer ,

Pfizer Inc. Leaders, Founders, and Executives: Who Are They?

Pfizer is a research-based pharmaceutical and biomedical giant. Get to know the Pfizer Inc. leaders, founders, and executives here ....

New York , United States , William Pao , Josephj Echevarria , Angela Hwang , Shantanu Narayen , Aamar Malik , Danr Littman , Mike Mcdermott , Ronalde Blaylock , Sally Susman , Susan Desmond Hellmann , Jamesc Smith , Olidia Fonseca , Mikael Dolsten , Doug Lankler , Helenh Hobbs , Charles Erhart , Aamir Malik , Suzanne Nora Johnson , Albert Bourla , Dave Denton , Payal Sahni Becher , Scott Gottlieb , James Quincey , Susan Hockfield ,

Cardiff Oncology Advances Colorectal Cancer Treatment - San Diego Business Journal

Cardiff Oncology Advances Colorectal Cancer Treatment - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Mark Erlander , Jamie Levine , Adam Schayowitz , Cardiff Oncology Inc , Pfizer Global Product Development , Cardiff Oncology , Pfizer Ignite ,

Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug. ....

Richa Kumari , James Levine , Mark Erlander , Kiki Patel , Gilmartin Group , Exchange Commission , Pfizer Global Product Development , Dana Farber Cancer Institute , Prnewswire Cardiff Oncology Inc , Cardiff Oncology Inc , Medicine Team Group Lead For Breast Cancer , Taft Communications , Cardiff Oncology , Chief Executive Officer , Pfizer Ignite , Vice President , Medicine Team Group Lead , Breast Cancer , Colorectal Cancer , Scientific Advisory Board , Private Securities Litigation Reform Act , Oncology Contact , Financial Officer , Months Ended June , Health Care Amp Hospitals , Medical Pharmaceuticals ,

Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship

- Advance to first-line RAS-mutated mCRC follows the strong signal from new clinical and preclinical data, and agreement with FDA -
- First-line mCRC represents substantial increase in patient. ....

Kiki Patel , Mark Erlander , James Levine , Adam Schayowitz , Fairooz Kabbinavar , Richa Kumari , Medicine Team Group Lead For Breast Cancer , Gilmartin Group , Taft Communications , Prnewswire Cardiff Oncology Inc , Cardiff Oncology Inc , Exchange Commission , Pfizer Inc , Pfizer Global Product Development , Pfizer Ignite , Cardiff Oncology , Chief Executive Officer , Vice President , Medicine Team Group Lead , Breast Cancer , Colorectal Cancer , Scientific Advisory Board , Chief Medical Officer , Private Securities Litigation Reform Act , Oncology Contact ,